Technology and innovation watch
ShareMUMBAI: Glenmark Pharmaceuticals has gained the upper hand in a legal battle against Merck over a cholesterol control pill after a US court rejected most of the American drug company’s patent claims.
A New Jersey District court rejected 10 of the 13 patent claims after Glenmark challenged Merck’s patent so that it can launch [...]
ShareMerck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted [...]
ShareDrug major Merck & Co said Tuesday that the U.S. District Court for the District of Delaware ruled against the company in a patent infringement suit against Teva Pharmaceuticals USA Inc. The suit is related to Merck’s chemotherapeutic agent Temodar’s patent.
The company said that in the ruling, Judge Sue Robinson said that Merck’s patent on [...]